Aquestive Therapeutics, Inc. (AQST) Discusses FDA Complete Response Letter and Next Steps for Anaphylm Epinephrine Sublingual Film Transcript

Group 1 - The conference call is hosted by Aquestive Therapeutics, featuring key executives including the CEO and CFO [1] - The call includes an overview of recent business developments followed by a Q&A session with additional executives [1] - A press release was issued prior to the call, and a recording along with supplemental materials will be available on the company's website [2]